OTC : ATHJF

Antisense Therapeutics Limited — Earnings Estimates

$0.012 USD

-$0.04 (-76.0%)

Volume
2.5K
Average Volume
390
Market Capitalization
$19.64M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$0.08
Year Low
$0.01
Day High
Day Low
Payout Ratio
Current Ratio

Annual earnings financials

ATHJF financial data with annual/quarterly toggle

ATHJF GAAP EPS - Annual & Quarterly

ATHJF Sales Revenue - Annual & Quarterly

ATHJF Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ATHJF Estimated and Actual Revenue by Quarter
ATHJF Estimated and Actual EPS by Quarter
ATHJF Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2024-06-30 1 -1.77M -1.77M -1.77M -1.77M -1.77M -1.77M
ATHJF Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2024-06-30 1 - - - 6.28M 6.28M 6.28M
ATHJF Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2024-06-30 1 1.77M 1.77M 1.77M 0 0 0 0